继发于年龄相关性黄斑变性的地图样萎缩患者T细胞趋化因子受体谱与萎缩进展速率的关系
这项单中心前瞻性观察研究纳入85例地图样萎缩(GA)患者和45名健康对照,平均随访13个月,用眼底自发荧光图像测定萎缩病灶进展速率(PR),用流式细胞术检测外周淋巴细胞趋化因子受体比例。GA患者CD8+T细胞CCR6比例低于健康对照,快速进展者CD4+T细胞CCR6比例低于慢速进展者;GA患者CD4+和CD8+T细胞CCR5比例高于健康对照。按ARMS2多态性分层后,高风险基因型患者CD8+T细胞CCR5水平显著低于低风险基因型患者。作者认为趋化因子受体在GA患者中失调,CCR6可能参与GA进展,是潜在干预靶点。
要点
- GA患者CD8+T细胞CCR6比例低于健康对照。
- 快速进展GA患者CD4+T细胞CCR6比例低于慢速进展患者。
- GA患者CD4+和CD8+T细胞CCR5比例高于健康对照;高风险ARMS2基因型患者CD8+T细胞CCR5低于低风险基因型。
核心结论
- 趋化因子受体在GA患者中失调,CCR6可能参与GA进展,是潜在干预靶点。
研究设计与样本
- 单中心前瞻性观察研究,纳入85例GA患者和45名健康对照,平均随访13个月。
- 用系列眼底自发荧光图像测定萎缩病灶进展速率,用流式细胞术检测外周淋巴细胞趋化因子受体比例。
主要发现
- GA患者CD8+T细胞CCR6比例低于健康对照。
- 快速进展GA患者CD4+T细胞CCR6比例低于慢速进展患者。
- GA患者CD4+和CD8+T细胞CCR5比例高于健康对照。
- 按ARMS2多态性分层后,高风险基因型患者CD8+T细胞CCR5水平显著低于低风险基因型患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Geographic atrophy (GA) secondary to age-related macular degeneration is a progressive retinal degenerative disease. Systemic chemokine receptors and known risk-associated single-nucleotide polymorphisms have been associated with GA pathogenesis. Because halting progression is pivotal for patients, we investigated the association of candidate chemokine receptors and progression rate (PR) of atrophic lesions in patients with GA. METHODS: This prospective observational study conducted at a single center included 85 patients with GA and 45 healthy controls. Patients were followed up after 13 months on average. Serial fundus autofluorescence images were used to determine the PR of atrophic lesions. The proportion of chemokine receptors on peripheral lymphocytes were determined by flow cytometric analysis. RESULTS: Patients with GA had a lower proportion of CCR6 on CD8+T cells compared to healthy controls. Importantly, the proportion of CCR6 on CD4+T cells was lower in patients with fast GA progression compared to patients with slow progression of disease, suggesting that dysregulation of CCR6 could be involved in progression of GA. We also found that GA patients had a markedly higher percentage of CCR5 on CD4+ and CD8+T cells compared to healthy controls. After stratification according to ARMS2 polymorphism, we found a significantly lower level of CCR5 on CD8+T cells among patients with high-risk genotypes compared with patients with the low-risk genotype. CONCLUSIONS: Our study finds that chemokine receptors are dysregulated in patients with GA and that CCR6 might be involved in GA progression, making it a potential target for intervention.
引用
- Martinez Villarruel Hinnerskov J, Krogh Nielsen M, Kai Thomsen A, et al. Chemokine Receptor Profile of T Cells and Progression Rate of Geographic Atrophy Secondary to Age-related Macular Degeneration. Invest Ophthalmol Vis Sci. 2024. PMID: 38165703. doi:10.1167/iovs.65.1.5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。